Cvs Health (CVS) Notes Payables (2009 - 2025)

Cvs Health (CVS) has reported Notes Payables for 16 consecutive years, with $1.2 billion the latest figure, recorded in Q3 2025.

• For the quarter ending Q3 2025, Notes Payables rose 55.88% year-over-year to $1.2 billion; the trailing twelve-month figure through Sep 2025 stood at $1.2 billion (up 55.88% YoY), and the FY2024 full-year result was $2.1 billion, up 959.5% from the prior year.
• Notes Payables fell to $1.2 billion in Q3 2025 per CVS's latest filing, from $3.0 billion in the prior quarter.
• Across five years, Notes Payables topped out at $3.0 billion in Q2 2025 and bottomed at $200.0 million in Q4 2023.
• Historically, Notes Payables has averaged $1.4 billion across 4 years, with a median of $1.2 billion in 2025.
• The sharpest annual moves came in 2024 and 2025: Notes Payables surged 959.5% in 2024, then tumbled 53.7% in 2025.
• Over 4 years, Notes Payables stood at $252.0 million in 2021, then retreated by 20.63% to $200.0 million in 2023, then soared by 959.5% to $2.1 billion in 2024, then plunged by 41.15% to $1.2 billion in 2025.
• According to Business Quant data, Notes Payables over the past three periods registered $1.2 billion, $3.0 billion, and $1.3 billion for Q3 2025, Q2 2025, and Q1 2025 respectively.